State of the Science Summit on GI Malignancies | Conference

Dr. Iqbal on the Biggest Advance in the Treatment of Neuroendocrine Tumors

November 6th 2018

Syma Iqbal, MD, associate professor of clinical medicine, Keck School of Medicine, University of Southern California, discusses the impact of peptide receptor radionuclide therapy (PRRT) on the treatment of patients with neuroendocrine tumors (NETs).

Dr. Barzi on Available and Emerging Neoadjuvant Approaches in Pancreatic Cancer

November 6th 2018

Afsaneh Barzi, MD, assistant professor of clinical medicine, Norris Comprehensive Cancer Center, University of Southern California, discusses available and emerging neoadjuvant strategies for the treatment of patients with nonmetastatic pancreatic cancer.

Treatment Updates Move Neuroendocrine Tumor Paradigm Forward

October 31st 2018

Syma Iqbal, MD, discusses the evolving treatment paradigm of neuroendocrine tumors.

Role of Immunotherapy May Expand in Gastric/GEJ Cancers

October 31st 2018

The second-line treatment of gastric and gastroesophageal junction cancers has shifted considerably in the last few years, due in part to the addition of immunotherapy for select subgroups of patients.

Dr. Lenz on the Benefit of Regorafenib in CRC

October 26th 2018

Heinz-Josef Lenz, MD, associate director for Adult Oncology and co-leader of the Gastrointestinal Cancers Program, USC Norris Comprehensive Cancer Center, discusses the benefit of regorafenib (Stivarga) in the treatment of patients with colorectal cancer (CRC).

Dr. Iqbal on Second- and Third-Line Therapies in Gastric Cancer

October 23rd 2018

Syma Iqbal, MD, associate professor of clinical medicine, Keck School of Medicine, University of Southern California, discusses second- and third-line therapies in gastric cancer.

Optimal Sequencing Key Next Step for HCC Paradigm

October 18th 2018

Anthony B. El-Khoueiry, MD, discusses the promising hepatocellular carcinoma treatment paradigm.

Expert Discusses Emerging Treatments in Early Pancreatic Cancer

October 17th 2018

Afsaneh Barzi, MD, discusses updates in the treatment of patients with pancreatic cancer, as well as the importance of genetic testing.

Lenz Highlights Ongoing Advances in mCRC

October 17th 2018

Heinz-Josef Lenz, MD, discusses the intersection between the molecular makeup of colorectal cancer and the development of novel therapies in the treatment paradigm.

Dr. El-Khoueiry Discusses Recent Combination Data in HCC

October 17th 2018

Anthony El-Khoueiry, MD, associate professor of clinical medicine, Keck School of Medicine, USC Norris Comprehensive Cancer Center, discusses recent combination data in hepatocellular carcinoma.